Swiss National Bank’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
GCL
TAL
BCM
MF
FTCM
Swiss National Bank's SWTX Position: Q2 2025 in Review
Swiss National Bank sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 115,300 shares — an estimated $5.09M sold.
Swiss National Bank first reported a position in SWTX in Q2 2020 and held it in 20 quarters. The position peaked at $5.09M in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.
- Swiss National Bank reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
- Swiss National Bank sold 115,300 SpringWorks Therapeutics shares in Q2 2025, an estimated $5.09M.
- Swiss National Bank first reported a position in SpringWorks Therapeutics in Q2 2020 and held it in 20 quarters.
- Swiss National Bank's SpringWorks Therapeutics position peaked at $5.09M in Q1 2025.
- 222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.
Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.